Private equity major Warburg Pincus has completed the buyout of DKSH’s healthcare business in China for CHF100 million ($99.45 million), marking the New York-headquartered investor’s first control deal in the country.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
